Wnt/β-catenin has been described as crucial for dorsal-ventral and antero-posterior patterning, playing multiple roles at different stages of development. Cholesterol-rich membrane microdomains (CRMMs), cholesterol-and sphingolipid-enriched domains of the plasma membrane, are known as platforms for signaling pathways. Although we have demonstrated the importance of the CRMMs for head development, how they participate in prechordal plate formation and embryo axis patterning remains an open question. Moreover, the participation of the CRMMs in the Wnt/β-catenin signaling pathway activity in vivo is unclear, particularly during embryonic development. In this study, we demonstrated that CRMMs disruption by methyl-beta-cyclodextrin (MβCD) potentiates the activation of the Wnt/β-catenin signaling pathway in vitro and in vivo during embryonic development, causing head defects by expanding the Wnt expression domain. Furthermore, we also found that the action of CRMMs depends on the microenvironmental context because it also works in conjunction with dkk1, when dkk1 is overexpressed. Thus, we propose CRMMs as a further mechanism of prechordal plate protection against the Wnt signals secreted by posterolateral cells, complementing the action of secreted antagonists.
Introduction
Embryonic development is mediated by signaling pathways that direct early embryonic axis formation in a coordinated fashion (De Robertis et al., 2000; Niehrs, 2004) . Among the signaling pathways that drive early embryonic development to acquire the vertebrate body plan, the Wnt/β-catenin pathway has been described as crucial for dorsal-ventral and antero-posterior patterning, playing multiple roles at different stages of development. Wnts are a family of secreted ligands crucial to Wnt signaling transduction. Wnts bind to the Frizzled (Fz) family of seven-pass transmembrane receptors that form a complex with the co-receptor LRP6 leading to the accumulation of β-catenin in the cytoplasm. The free β-catenin is translocated to the nucleus, thus activating the Wnt/β-catenin signaling pathway and targeting gene expression. The Wnt/β-catenin maternal activation is essential to the Spemann's organizer formation, which, at the beginning of zygotic transcription, becomes a source of secreted signaling molecules that induce head or trunk development, constituting the head and trunk Organizers (Harland and Gerhart, 1997; Niehrs, 1999; Sasai and De Robertis, 1997) .
The nature of molecules produced by the Organizer has been described as antagonists of the growth factors secreted by the ventral side of the embryo during gastrulation, and it is essential to ensure head development Niehrs, 2004; Zhang et al., 2012) . If the Wnt antagonists fail to be secreted, the head is not induced, and the embryo might become posteriorized. On the other hand, if the antagonists are overexpressed, the embryo becomes anteriorized or secondary heads might develop. To specify the anteroposterior axis during gastrulation of Xenopus embryos, the Wnt/β-catenin signaling pathway works in a gradient, where the Wnt ligands act as morphogens. Thus, high Wnt activity promotes posterior patterning while low or no Wnt activity is required for anterior head formation, making a postero-anterior gradient of activation. The anterior region of the embryo is essentially protected from Wnt activity through the secreted antagonists, firstly secreted by the Organizer during gastrulation, and subsequently secreted by the prechordal plate, the head Organizer, during neurulation (De Robertis et al., 2000; Harland and Gerhart, 1997; Kazanskaya et al., 2000; Kuroda et al., 2004) . This is a well-controlled engine, and to guarantee an anterior zone free of Wnts, many molecules with specific mechanisms of action are expressed. Some secreted molecules inhibit Wnt signaling by binding to Wnt ligands and blocking its interactions with receptors such as sFRPs, WIF-1, and Cerberus. Other molecules block complex formation with Wnt ligands by binding to receptors such as Dkk1, Wise/SOST and IGFBP-4. There are also enzymes that cleave Wnt molecules thus inactivating them, such as Tiki and Notum (Niehrs, 2004; Zhang et al., 2012; Zhang et al., 2015) .
Cholesterol-rich membrane microdomains (CRMMs), cholesteroland sphingolipid-enriched domains of the plasma membrane, are known as platforms for signaling pathways. Their participation in signaling events has been described as a set of transmembrane domain proteins favored by a particular lipid microenvironment over another (Bauer and Pelkmans, 2006; Lingwood and Simons, 2010) . Cholesterol, the major component of the CRMMs, plays a structural/stabilizing role and its removal from the cell surface results in disorganization of these domains (Pike and Miller, 1998; Roper et al., 2000) . Low cholesterol levels during embryonic development result in holoprosencephaly (Cooper et al., 2003; Lanoue et al., 1997) . Smith-Lemli-Opitz syndrome (SLOS) is the most common human disorder involving cholesterol biosynthesis, and results from mutations in 7-dehydrocholesterol reductase (DHCR7), the enzyme implicated in the final step of cholesterol biosynthesis. Inhibiting DHCR7 enzymatic activity and, consequently, cholesterol biosynthesis leads to a range of malformations such as head defects (Cooper et al., 2003) . In Xenopus, both gain and loss of function of DHCR7 cause anterior neural plate defects, particularly in the eye field, where it results in eye defects, indicating that cholesterol biosynthesis requires strict control during development (Tadjuidje and Hollemann, 2006) . However, how cholesterol and its relationship to the CRMM function participate in these processes remains unclear. We previously showed that CRMM is essential for head development and crucial for prechordal plate morphology and function in Xenopus and chick embryos, whereas its disruption at the blastula stage of Xenopus is not implicated in the Spemann Organizer formation (Reis et al., 2012) . Although we have demonstrated the importance of CRMMs for head development, how they participate in prechordal plate formation and embryo axis patterning remains an open question. Moreover, the participation of the CRMMs in the Wnt/β-catenin signaling pathway activity in vivo is unknown, particularly during embryonic development. Here, we demonstrated that CRMMs disruption by methyl-beta-cyclodextrin (MβCD) causes the activation of the Wnt/β-catenin signaling pathway in vitro and in vivo during embryonic development, causing head defects by expanding the Wnt expression domain. Furthermore, we also found that the action of CRMMs depends on the microenvironmental context because it also works in conjunction with dkk1 when dkk1 is overexpressed.
Materials and methods

Embryo manipulation, microinjection and phenotype analysis
Adult frogs (Nasco Inc., WI, USA) were stimulated with Human chorionic gonadotropin (CG10, Sigma). Xenopus embryos were obtained by in vitro fertilization and staged according to Nieuwkoop and Farber (Nieuwkoop, 1967) . Blastocoel microinjections were performed in stage 9 embryos, using 50 nl of 40 mM methyl-β-cyclodextrin (Sigma, St. Louis, MO, USA) diluted in H 2 O per embryo. As controls, embryos were not injected or were injected with 40 nl of H 2 O. Microinjected embryos were developed until the gastrula, neurula, early and late tailbud stages, and used for the procedures described as follows. Head anlage dissection and recombination with posterior region of the embryo injected or not with MβCD were performed according to Reis et al. (2012) . For synthetic wnt8, β-galactosidase and dkk1 mRNAs, the plasmids were linearized with NotI and transcribed with SP6 RNA polymerase using the mMessage mMachine kit (Applied Biosystems). Venuswnt8 plasmid was not linearized. The mRNA was transcribed and microinjected according to Mii and Taira (2009) . 4-cell stage Xenopus laevis embryos were microinjected with β-galactosidase mRNA at 50 pg RNA/embryo as a tracer and wnt8 or dkk1 mRNA in the same blastomere. The β-catenin morpholino (TTACAACCGTTTCCAAAGAACCAGG) was injected at the 32-cell stage in the dorsal blastomeres targeting the anterior territory of the embryo.
Animal cap assay
wnt8 mRNA was injected at 4-cell stage (1 pg per embryo) and 40 mM MβCD was injected into blastocoel at stage 8 of Xenopus laevis embryos. The embryos were cultured until stage 8.5 when the animal caps were dissected and cultured until stage 10. Total RNA was extracted from whole embryos or cultured animal explants with TRIzol reagent (Ambion) following the manufacturer's instruction. RT-PCR was performed with a Superscript amplification system (Invitrogen). For each lane of one given experiment, 10-15 animal caps were pooled and analyzed. Non-injected sibling embryos serve as a positive control in the first lane of PCR gel. ef1α was used as a cDNA loading control. Primer sequences were obtained through the De Robertis lab home page (http:// www.hhmi.ucla.edu/derobertis/).
In situ hybridization
Xenopus embryos were fixed in MEMFA for 2 h at room temperature or at 4°C overnight, and then dehydrated using a methanol series. Whole-mount in situ hybridization was performed according to (Abreu et al., 2002) with modifications suggested by (Reversade and De Robertis, 2005 4-cell stage embryos were injected into the ventral or dorsal marginal zone with 300 pg of luciferase reporter plasmid (S01234-Luc) and 10 pg of TK-renilla, alone or in combination with 10 pg of wnt8 mRNA. When the embryos reached stage 9 they were injected with MβCD into the blastocoel. At stage 10, the embryos were lysed for luciferase activity detection. Alternatively, embryos were injected at 4-cell stage with 80 pg TOPflash and 10 pg TK-Renilla plasmids and, at stage 9, they were injected with MβCD. The TOPflash/TK-Renilla injected embryos were lysed at stage 10 or 13 for luciferase detection. Triplicates of four embryos were lysed according the manufacturer's protocol (Dual-Luciferase Reporter System, Promega) and 20 μl of embryo lysate were used for luciferase detection and normalized by renilla luciferase activity.
Western blot analysis
RKO-pBAR/Renilla cells have been treated with 5 mM MβCD during 30 min. After 24 h of treatment, Western blot analysis was performed as described previously (Amado et al., 2014) . For secreted protein detection, Wnt3a-secreting L-cell conditioned medium was concentrated by using Amicon Ultra 0.5 mL filters (Merck Millipore). Protein concentrations were determined using Bradford Protein Assay (Bio-Rad). For conditioned medium, we also used bovine serum albumin (BSA) standard stained with Coomassie blue in SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The same amount of protein was loaded in the gel for each lane. The antibodies used in this study were: anti-β-catenin (1:1000 Sigma, MO, USA), anti-α-tubulin (1:2000, Sigma, MO, USA), antiCyclinD1 (1:2000, Cell Signaling, MA, USA), and anti-Wnt3a (1:500, Cell Signaling, MA, USA). Secondary antibodies conjugated with horseradish peroxidase were used to probe the membranes and the reaction was visualized using a Pierce Fast Western Blot Kit, SuperSignal West Pico Chemiluminescent Substrate, (Rockford, IL, USA).
Statistical analysis
Student's t-test or Mann-Whitney test was used in statistical analysis. The P values are described and specified in each figure legend.
P values b 0.05 (P b 0.05) were considered statistically significant. All analyzes were done using Microsoft Excel 2013 or GraphPad Prism 6.05 softwares.
Results
Maternal Wnt signaling is not affected by MβCD
In a previous study, we demonstrated that cholesterol deletion by injection of MβCD into blastocoel at stage 9 of Xenopus laevis induced forebrain defects (Reis et al., 2012) . In this study, we have followed the embryonic development after cholesterol depletion and noticed that neural plate formation is altered in the anterior region. When the neural plate is forming, cell movements involved in this process are marked by the pigmentation in the dorsal side of the embryo, forming a wide line along the antero-posterior axis. Following neural plate formation, we observed an irregular pigmentation pattern after cholesterol depletion, mainly in the anterior neural plate that persists in the subsequent stages of development (Fig. S1 ). Given these observations, we asked whether this could be a consequence of alterations in the Wnt/ β-catenin signaling pathway because defects in the neural plate formation are traditionally related to this signaling pathway. Therefore, we first assayed the maternal Wnt/β-catenin pathway by injecting wnt8 mRNA at the 4-cell stage and analyzed Xnr3 expression in the dissected animal cap. We did not observe any differences between wnt8 injected animal caps and those injected with both wnt8 and MβCD at stage 9 ( Fig. 1A-A′) . Moreover, the MβCD injection alone was not able to induce Xnr3 expression in the animal cap (Fig. 1A -A′, compare with cap control); Xbra expression was not altered either. In order to check whether early MβCD treatment might alter the Wnt signaling pathway, we bathed the embryos in MβCD solution. The MβCD solution has been diluted to 40 mM or 100 mM in Barth solution and the embryos were cultured from the 4-cell stage to stage 8. The embryos developed normally and the expression of Xnr3 and siamois was not altered (Fig. 1B) . We also conducted a siamois-reporter assay (S01234) to analyze the maternal Wnt/β-catenin pathway in Xenopus embryos. We induced the canonical Wnt signaling pathway by injecting wnt8 mRNA at the 4-cell stage, and noticed the activation of the reporter gene (Fig. 1C) . However, when the MβCD injection was conducted, we did not observe any difference in the reporter activity level (Fig. 1C) . These results suggest that the maternal Wnt signaling is not affected by the cholesterolrich membrane microdomains disruption and the phenotype observed is not due to its alteration.
Cholesterol depletion by MβCD alters pax6 expression
CRMM integrity after MBT is essential for proper head development of Xenopus laevis and chicken embryos ( Fig. 1 and Reis et al., 2012) . To determine how CRMM disruption affects the dynamic gene expression, we injected MβCD in a Xenopus tropicalis transgenic line that expresses the pax6-GFP gene (Nakayama et al., 2015) . pax6 is a zygotic gene expressed from stage 10 onward in Xenopus embryos; it is an important central nervous system marker expressed in the telencephalon, diencephalon and anterior spinal cord ( Fig. 2A-A′′′) . Furthermore, we injected MβCD at stage 9 (soon before pax6 begins to be expressed, at stage 10), so we could visualize the effects of cholesterol depletion directly on pax6 expression. pax6-GFP anterior expression domain was affected (30% of injected embryos) when cholesterol was depleted, and a mild phenotype was observed characterized by smaller eye field and fusion of brain hemispheres in the midline (Fig. 2B-B′′′) . The entire anterior expression of pax6 was abolished (60% of injected embryos), yielding a severe phenotype where it was possible to visualize the spinal cord expression (Fig. 2C-C′′′) . Thus, CRMMs disruption by MβCD disturbs pax6-GFP expression in a Xenopus tropicalis transgenic line.
The MβCD cholesterol depletion phenotype is head autonomous
Knowing that CRMMs disruption by MβCD affects mainly anterior development, we investigated whether an intact posterior region could rescue the MβCD affected head. To analyze this possibility, we performed transplantation experiments using Xenopus laevis embryos, in which the head anlage of MβCD injected embryos was isolated and grafted in control embryos that were previously dissected and had their head anlages excised; a control head anlage was also grafted in MβCD injected embryos. The transplants were carried out at stage 12.5 (Fig. 3A) . We observed that the control head anlage could give rise to a proper head in a control embryo (Fig. 3C) and that when we transplanted a control head anlage in a posterior MβCD injected embryo, the head is properly formed (Fig. 3D) . Moreover, when a head anlage dissected from an MβCD injected embryo was grafted in a control embryo it was not able to form a head, indicating that the posterior region of the control embryo was not able to rescue the posteriorized head anlage caused by cholesterol depletion (Fig. 3E-F) . Altogether, these results suggest that the microcephaly caused by CRMMs disruption is head autonomous, and the integrity of the posterior region of the embryo is not sufficient to rescue the head phenotype.
CRMM disruption enhances the Wnt/β-catenin signaling transcriptional activation
Because we found that the CRMMs disruption causes mainly head impairment and it is similar to the posteriorization caused by zygotic Wnt signaling pathway overactivation, we wondered whether CRMMs disruption could make the Wnt-free anterior territory vulnerable to Wnt signaling activation. To do this, we performed RT-PCR of stage 13 whole embryos and attempted wnt3a, wnt11 and wnt5a amplification, so we could study the canonical and non-canonical Wnt signaling pathways. We noticed a subtle enhancement in wnt3a expression after MβCD injection (Fig. 4A, left) . We decided to dissect the head anlage to verify the wnt3a expression anteriorly. Indeed, wnt3a expression is enhanced after cholesterol depletion, and so is the expression of the zygotic Wnt/β-catenin target genes myf5 and myoD (Fig. 4A, right) . The densitometric analysis of the RT-PCR bands is showed in the Fig. S2 , and represents at least five independent experiments. We examined the effect of cholesterol depletion on the Wnt signaling activity by injecting the TOP-FLASH construct, a luciferase reporter assay which responds to canonical Wnt signaling (van de Wetering et al., 1997) . The TOP-FLASH construct was injected at the 4-cells stage, co-injected (or not, in the case of the control) with wnt8 mRNA; the MβCD was injected at stage 9 and the embryos were lysed for luciferase reading at stages 10 or 13. Analyses at stage 10 did not show any difference in luciferase activity (Fig. 4B) . On the other hand, when the analyses were performed at stage 13, this approach revealed the enhancement of the reporter activity when wnt8 and MβCD were co-injected, but not when wnt8 was injected by itself (Fig. 4B) . We also examined the effects of cholesterol depletion on the Wnt/β-catenin signaling in vitro by performing luciferase assays after treating RKO cells with MβCD. The RKO human colon carcinoma cell line is responsive to Wnt signaling pathway by expression of a firefly luciferase-based β-catenin-activated reporter (pBAR), along with Renilla luciferase under the control of the constitutively active thymidine kinase promoter for normalization (Major et al., 2007) . We treated the RKO cells with two different amounts of Wnt3a-conditioned medium, 15% and 25%, and increasing concentrations of MβCD (0.5, 2 and 5 mM). The MβCD treatment itself was not able to activate the Wnt/β-catenin signaling pathway. On the other hand, the MβCD treatment induced a significant activation of gene reporter activity in a concentration-dependent manner in the presence of the conditioned medium, suggesting that MβCD potentiates the reporter activation performed by Wnt3a (Fig. 4C) . The RKO cells do not present β-catenin localized at the plasma membrane (Major et al., 2007) . Thus, in the absence of the Wnt3a-conditioned medium or under the MβCD treatment, we did not detect β-catenin in our western blot analysis. However, our experiment revealed the enhancement in β-catenin protein content after the 5 mM MβCD treatment with the conditioned medium (Fig. 4D) . Moreover, the target gene of Wnt/β-catenin signaling CyclinD1 was increased in the presence of the MβCD (Fig. 4E) . To check whether the plasma cholesterol depletion would be able to enhance Wnt secretion, we treated the L-cell lineage, which secretes Wnt to the medium, with MβCD and analyzed its conditioned medium in RKO cells. In fact, after cholesterol depletion, the conditioned medium induced higher activation of Wnt signaling (Fig. 4F) . Furthermore, western blot analysis detected an increase in total Wnt protein secreted to the medium (Fig. 4G) . The same concentration of protein was loaded in each lane of the gel. Coomassie blue stained gel after electrophoresis is showed as loading control. In addition, we have injected Venus-Wnt8 mRNA in one blastomere at 4-cell stage embryos, and analyzed the animal cap Wnt8 expression after MβCD injection. In fact, higher level of Venus-Wnt8 expression was seen after cholesterol depletion by MβCD (Fig. S3) . These results show that CRMMs disruption potentiates Wnt ligand activity, enhancing Wnt/β-catenin signaling likely by promoting its availability/secretion in the anterior region of the embryo.
Anterior inhibition of Wnt/β-catenin signaling pathway prevents the CRMMs disruption embryo phenotype
It is known that the injection of 20 ng of β-catenin morpholino at the 32-cell stage causes excessive anterior neural development (Heasman et al., 2000) . We injected 32-cell stage embryos with β-catenin morpholino, targeting four dorsal animal cells (A-tier) in order to test the participation of Wnt/β-catenin signaling in the MβCD head phenotype (Fig. 5A) . The cholesterol depletion by MβCD leads to head defects (Fig. 5C ) similar to the phenotype observed when the zygotic Wnt/β-catenin signaling pathway is overactive (Heasman et al., 2000) . The A-tier injection of β-catenin morpholino at 32-cell stage induced an abnormal cement gland formation (Fig. 5D, D′) . The injection of β-catenin morpholino at the 32-cell stage and MβCD at stage 9 blocked the head defects caused by cholesterol depletion (Fig. 5E, E′) , indicating that the anterior defects induced by MβCD require anterior β-catenin.
CRMMs disruption increases Wnt field activity during development
The otx2 gene is an anterior marker expressed in the presumptive prosencephalon (Fig. 6A) ; its expression domain is reduced upon cholesterol depletion by MβCD (Fig. 6B) . It has been shown that the otx2 expression domain is inhibited in the wnt8-expressing area (Mii and Taira, 2009) . To test whether the head defects induced by MβCD are due to an enhancement of Wnt signaling domain anteriorly, we have co-injected wnt8 DNA and the cell lineage tracer β-galactosidase DNA into 4-cell stage embryos and checked otx2 expression, as well as the distance of otx2 from the Wnt source at stage 12.5. This injection caused a displacement of otx2 expression from the wnt8-expressing area (Fig. 6C ). When these embryos were injected with MβCD at stage 9, we observed that the area downregulating otx2 expression expanded further from the wnt8 source (Fig. 6D) , most of the injected embryos had the otx2 expression completely abolished, and the source of wnt8 diffused anteriorly (Fig. 6E) . These results strongly suggest that cholesterol depletion by MβCD is able to shift the Wnt gradient anteriorly, affecting the local gene expression and head patterning.
3.7. CRMMs disruption affects dkk1 expression and spreading dkk1 is an important Wnt antagonist expressed in the endomesoderm and responsible for inducing a functional prechordal plate, which is important for the specification of anterior structures (Kazanskaya et al., 2000) . Because cholesterol depletion by MβCD causes head development as a consequence of prechordal plate disruption and Dkk1 is able to partially rescue the head phenotype (Reis et al., 2012) , it raised the question whether dkk1 expression might be affected by MβCD. Indeed, the dkk1 expression domain is reduced during neurulation but it is mostly expressed during the gastrula stage (Fig. 7A-D) . We attempted to rescue the head phenotype caused by cholesterol depletion (Fig. 7F) by injecting dkk1 mRNA at the 4-cell stage. The injection of 10 pg of dkk1 leads to an increase of anterior structures (Fig.  7G) . Surprisingly, the injection of dkk1 mRNA at the 4-cell stage and MβCD at stage 9 caused excessive anterior development, as observed by the huge cement gland (Fig. 7H) .
In order to analyze whether the effects of cholesterol depletion on the embryo overexpressing dkk1 are related to the spreading of dkk1, we examined otx2 expression after dkk1 and MβCD injections. As expected, MβCD injection causes a reduction of the otx2 expression domain ( Fig. 8B ) and dkk1 mRNA injection leads to an enhancement of the otx2 expression domain (Fig. 8C) . Nevertheless, the co-injection of dkk1 and MβCD induced an enlargement of the anterior region, as seen by the expansion of the otx2 expression domain (Fig. 8D) . These results demonstrate that cholesterol depletion by MβCD might influence and/or potentiate the spreading of Dkk1 farther away from its source. As it is expressed in the prechordal plate, its domain is increased leading to an excessive anterior development.
Discussion
In this study, we assessed CRMMs role in head development and antero-posterior patterning. We observed that CRMMs act as an endogenous inhibitor of the Wnt/β-catenin signaling pathway in the anterior region during the antero-posterior axis specification and head development of vertebrate embryos. CRMMs disruption by cholesterol depletion causes the loss of anterior structures as a result of the anterior spread of the Wnt morphogen, which enhances the gradient of the Wnt activity. Moreover, we have noticed that the roles of the CRMMs depend on the tissue context because we have observed that there is a time window for their action (Reis et al., 2012) and that Dkk1 (an antagonist of the Wnt pathway) overexpression can increase the anterior region of the embryo.
The CRMMs are known by their ability to compartmentalize cellular processes and participate in cell signaling events. The caveolae are Caveolin-enriched CRMMs. The protein Caveolin was the first integral protein characterized as a lipid raft modifier, thus serving as a marker protein of these CRMMs (Lisanti et al., 1994; Rothberg et al., 1990) . The Caveolin protein possesses a scaffold domain where different proteins associate to initiate signaling cascades (Parton and Simons, 2007) . It has been shown that there are caveolar and planar CRMMs; they both have an enrichment of cholesterol as the major structural skeleton and its removal results in their disruption (Galbiati et al., 2001; Reis et al., 2012; Rothberg et al., 1992; Simons and Ikonen, 1997) . In the last decade, it has been shown that some signaling pathways were related to the CRMMs and that signal transduction was dependent on those membrane domains (Buschiazzo et al., 2008; Corley Mastick et al., 2001; Engelman, 2005; Lichtenberg et al., 2005; Simons and Ikonen, 1997; Stauffer and Meyer, 1997; Viola et al., 1999) . However, most reports relating CRMMs to the signaling pathways did not show the entire platforms as responsible for the signal transduction but rather the Caveolin protein itself, particularly for the Wnt/β-catenin signaling pathway. Particularly, Caveolin has been shown to be essential for the internalization of the Wnt/β-catenin signaling receptors complex upon Wnt3a stimulation. The downregulation of the Caveolin1 protein blocks LRP6 internalization and β-catenin accumulation in the cytoplasm, suppressing Wnt3a signaling (Yamamoto et al., 2006 (Yamamoto et al., , 2008 . However, as cholesterol depletion is able to disorganize both caveolar and planar CRMMs, and the presence of Caveolin in the prechordal plate was never shown, we suggest a new mechanism for the role of CRMMs during early head development: CRMMs represent a protective mechanism of the prechordal plate against Wnt signaling activity, operating in addition to the secreted antagonist molecules. We observed that MβCD injection at stage 9 enhances Wnt signaling activation anteriorly in Xenopus embryos and in RKO-pBAR/Renilla cells in vitro, suggesting that these microdomains have a role in restricting the activation of Wnt signaling pathway. Moreover, the presence of the β-catenin morpholino in the anterior region of the embryos prevented the head defects caused by cholesterol depletion (Fig. 5) . The injection was performed at the 32-cell stage in order to target early zygotic Wnt signaling (Heasman et al., 2000) because maternal Wnt signaling was not affected by the stage 9 MβCD injection (Fig. 4) . These results suggest that the activation of the Wnt/β-catenin signaling pathway in the anterior region of the embryo is achieved by CRMMs disruption.
The Wnt signaling activation accomplished by MβCD is only observed in the presence of the ligand, as assayed by our in vitro model (Fig. 3) , though it also probably happens in the embryonic context. The Wnt ligand from the posterolateral cells, which is secreted to activate this signaling in a paracrine mode, might invade the anterior territory after cholesterol depletion leading to the head defects.
The Xenopus tropicalis pax6-GFP transgenic line showed the effects of cholesterol depletion on the most anterior encephalon. Pax6 codes for a highly conserved transcriptional regulator (Callaerts et al., 1997) . It is critical for forebrain development, establishing the dorsal-ventral boundary of the telencephalon (Georgala et al., 2011) . A Pax6 loss-offunction is involved in the human condition called aniridia, characterized by the congenital malformation of the eyes and brain (Mitchell et al., 2003; Sisodiya et al., 2001) . Pax6 null mice display enhancement of the ventral gene expression domain, rather than the dorsal (Quinn et al., 2007; Stoykova et al., 1996) . Indeed, cholesterol depletion leads to the pax6 anterior expression domain reduction in mild phenotypes, while we have observed the complete absence of pax6 anterior expression in the severe phenotype (Fig. 1) . Furthermore, pax6 has been linked to the Wnt pathway as a canonical Wnt signaling inhibitor by controlling the gene regulatory network responsible for its activation/inhibition (Jami et al., 2013) . Thus, in the absence/reduction of the pax6 expression domain, the anterior tissue loses another mechanism of Wnt inhibition. In addition, dkk1 also has its domain expression reduced after cholesterol depletion by MβCD (Fig. 7) . Dkk1 is one of the major Wnt inhibitors secreted by the prechordal plate responsible for head patterning (Kazanskaya et al., 2000) . We attempted to rescue the CRMMs disruption phenotype by injecting dkk1 mRNA at the 4-cell stage in the dorsal blastomeres. However, the cholesterol depletion potentiated the effects of the dkk1 injection, leading to a greatly increased anterior territory (Fig. 7H) . This finding suggests that the CRMMs action depends on the tissue context. Dkk1 started to be transcribed and secreted in greater amounts than it is normally secreted before the MβCD injection. When the CRMMs were disrupted, it potentiated the spread of Dkk1, rather than the spread of Wnt. Another possibility is that Wnt was also spread as a result of the CRMMs disruption, but the higher amounts of Dkk1 blocked Wnt diffusion, increasing the otx2 positive territory (Fig. 8D ). This finding also explains why it is possible to rescue partially the head phenotype through tissue transplantation (Reis et al., 2012) . The transplantation was performed at stage 12.5 and we provided a source of dkk1 secretion to the head anlage. The duration of the exposition and the amount of the secreted dkk1 was smaller and restricted to the head anlage, more similar to the physiological conditions. This finding is consistent with our in vitro results. When we treated the RKO cells with the Wnt antagonists and MβCD, the inhibition of the Wnt/β-catenin signaling pathway was also partial, and dkk1 and Fzb were not able to block completely the activation performed by the MβCD (not shown).
The CRMMs are highly dynamic in terms of composition and function. We previously reported that during the early stages of Xenopus development, such as the 4-cell stage, blastula and gastrula, the neutral lipid and phospholipid content of CRMMs is not the same (Reis et al., 2012) ; this finding might be related to the specific functions of these domains during development. Further studies must be conducted to correlate CRMMs functions to other specific events of the embryonic development. Based on our results, we propose the following model for the participation of CRMMs during antero-posterior patterning and head development: in normal conditions, CRMMs play an important role in the antero-posterior axis specification by controlling the activation of Wnt/β-catenin signaling and, together with the secreted antagonists, ensure the head development. Thus, CRMMs protect the prechordal plate from Wnt ligands secreted by posterolateral cells as an additional system of Wnt inhibition. In addition, through cholesterol depletion, the prechordal plate loses that mechanism of protection, and with dkk1 expression being reduced during neurulation, it leaves the anterior territory vulnerable to Wnt invasion and signaling activation. Thereby, the posteriorized phenotype is generated, blocking neural anterior development (Fig. 9 ). In conclusion, this study demonstrates that the CRMMs might be an additional mechanism deployed by the plasma membrane in the prechordal plate to protect the anterior territory from Wnt posteriorizing signals.
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